9/4/24 16:13 | 8/30/24 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Leiden Jeffrey M | MA | DO | Exec CB | S | -1,888 | 499.00 | 0 | -4 | -27 | 10 | D | | | | | | | | | | | | | | |
2/16/24 16:07 | 2/14/24 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Leiden Jeffrey M | MA | DO | Exec CB | S.m | -3,777 | 419.10 | 0 | -9 | -33 | 18 | D | | | | | | | | | | | | | | |
2/14/24 16:04 | 2/12/24 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Leiden Jeffrey M | MA | DO | Exec CB | S.m | -1,423 | 419.42 | 0 | -3 | -11 | 27 | D | | | | | | | | | | | | | | |
1/10/24 16:06 | 1/8/24 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Leiden Jeffrey M | MA | DO | Exec CB | S | -2,786 | 419.07 | 0 | -7 | -70 | 3 | D | | | | | | | | | | | | | | |
12/15/23 16:33 | 12/13/23 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Leiden Jeffrey M | MA | DO | Exec CB | S | -5,334 | 399.42 | 0 | -13 | -58 | 10 | D | | | | | | | | | | | | | | |
10/18/23 16:17 | 10/16/23 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Leiden Jeffrey M | MA | DO | Exec CB | S | -4,848 | 374.00 | 0 | -13 | -36 | 23 | D | | | | | | | | | | | | | | |
5/9/23 16:10 | 5/5/23 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Leiden Jeffrey M | MA | DO | Exec CB | S.m | -700 | 349.25 | 0 | -2 | -5 | 36 | D | | | | | | | | | | | | | | |
5/4/23 16:50 | 5/2/23 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Leiden Jeffrey M | MA | DO | Exec CB | S.m | -3,835 | 349.98 | 0 | -11 | -22 | 38 | D | | | | | | | | | | | | | | |
7/27/22 16:17 | 7/25/22 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Leiden Jeffrey M | MA | DO | Exec CB | S.d | -37,164 | 281.38 | 0 | -132 | -98 | 3 | D | | | | | | | | | | | | | | |